AK-106 (AK106-001616) is a selective cytosolic phospholipase A2 (cPLA2) inhibitor. It exhibits analgesic effects comparable to NSAIDs and is utilized in research to study inflammatory pathways, with applications in both in vitro biochemical assays and in vivo models of pain and inflammation.
Molekulargewicht:
427.49
CAS Nummer:
[590416-75-4]
Formel:
C26H25N3O3
Target-Kategorie:
Others,Phospholipase
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten